Cystic fibrosis (CF) is a common genetic disorder in the United States, affecting approx 1 in 3200 white and 1 in 15,000 black live births (1). This disease results in abnormal sodium and chloride transport resulting from mutations in the CF transmembrane conductance regulator (CFTR) (2). Mutations in the CFTR alter the osmolarity of body secretions, resulting in lung and gastrointestinal (GI) complications. Blocked bronchial airways, lung infections, and GI disturbances involving maldigestion and malabsorption are common consequences of CF.